Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXBT7K
|
||||
| Drug Name |
(2E)-4-(dimethylamino)-N-[7-ethoxy-4-({4-[2-fluoro-1-(fluoromethyl)ethoxy]-3,6-dioxocyclohexa-1,4-dien-1-yl}amino)quinazolin-6-yl]but-2-enamide
|
||||
| Synonyms |
CHEMBL243410
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H27F2N5O5
|
||||
| Canonical SMILES |
CCOc1cc2ncnc(NC3=CC(=O)C(=CC3=O)OC(CF)CF)c2cc1NC(=O)\\C=C\\CN(C)C
|
||||
| InChI |
InChI=1S/C25H27F2N5O5/c1-4-36-22-10-17-16(8-19(22)30-24(35)6-5-7-32(2)3)25(29-14-28-17)31-18-9-21(34)23(11-20(18)33)37-15(12-26)13-27/h5-6,8-11,14-15H,4,7,12-13H2,1-3H3,(H,30,35)(H,28,29,31)/b6-5+
|
||||
| InChIKey |
DUIPPPAQSCDKSG-AATRIKPKSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Epidermal growth factor receptor III | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.